SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 117 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $297 | -3.9% | 54,309 | +76.0% | 0.00% | – |
| Q1 2024 | $309 | +86.1% | 30,861 | -23.9% | 0.00% | – |
| Q4 2023 | $166 | +11.4% | 40,564 | +5.4% | 0.00% | – |
| Q3 2023 | $149 | -34.4% | 38,482 | +1.2% | 0.00% | – |
| Q2 2023 | $227 | +73.3% | 38,039 | -5.1% | 0.00% | – |
| Q1 2023 | $131 | -45.9% | 40,078 | -34.7% | 0.00% | – |
| Q4 2022 | $242 | -99.9% | 61,378 | -0.1% | 0.00% | -100.0% |
| Q3 2022 | $369,000 | -6.3% | 61,464 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $394,000 | -22.3% | 61,269 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $507,000 | -46.6% | 61,322 | -0.0% | 0.00% | 0.0% |
| Q4 2021 | $949,000 | -23.1% | 61,323 | +11.9% | 0.00% | 0.0% |
| Q3 2021 | $1,234,000 | +171.8% | 54,792 | +137.2% | 0.00% | – |
| Q2 2021 | $454,000 | -55.4% | 23,100 | -24.0% | 0.00% | -100.0% |
| Q1 2021 | $1,017,000 | – | 30,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trustees of Columbia University in the City of New York | 281,250 | $6,334,000 | 9.69% |
| Flagship Pioneering Inc. | 34,239,018 | $771,063,000 | 8.08% |
| Crestline Management, LP | 3,210,937 | $72,310,000 | 6.80% |
| SB Management Ltd | 2,209,004 | $49,747,000 | 5.10% |
| Omega Fund Management, LLC | 843,750 | $19,001,000 | 2.13% |
| HARVARD MANAGEMENT CO INC | 1,163,601 | $26,204,000 | 1.54% |
| Alphabet Inc. | 2,812,500 | $63,338,000 | 1.50% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 387,508 | $8,727,000 | 1.03% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,131,249 | $93,036,000 | 0.53% |
| Dragoneer Investment Group | 1,500,000 | $33,780,000 | 0.44% |